Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations

Immune-related adverse events (irAEs) are side effects of immune checkpoint inhibitor therapy (ICI). While common irAEs have been well characterized, there are more limited data on rare immune related adverse events (RirAEs) due to low incidence. Lack of characterization of these entities has led to...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Benjamin C. Park, Sathya Narayanan, Alexander Gavralidis, Fei Ye, Run Fan, Ryan J. Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M. Balko, Matteo S. Carlino, Georgina V. Long, Leyre Zubiri, Alexander M. Menzies, Douglas B. Johnson
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Taylor & Francis Group 2023-12-01
Серія:	OncoImmunology
Предмети:	Immune checkpoint inhibitor toxicity immune checkpoint inhibitors immune related adverse events melanoma rare immune related adverse events uncommon immune related adverse events
Онлайн доступ:	https://www.tandfonline.com/doi/10.1080/2162402X.2023.2188719
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations

Схожі ресурси